Abstract

The rapid fluorescent focus inhibition test (RFFIT) is routinely used in the United States to measure rabies virus neutralizing antibodies (rVNA). RFFIT has a long history of reproducible and reliable results. The test has been modified over the years to use smaller volumes of reagents and samples, but requires a 50 μL minimum volume of test serum. To conduct pathogenesis studies, small laboratory animals such as mice are regularly tested for rVNA, but the minimum volume for a standard RFFIT may be impossible to obtain, particularly in scenarios of repeated sampling. To address this problem, a micro-neutralization test was developed previously. In the current study, the micro-neutralization test was compared to the RFFIT using 129 mouse serum samples from rabies vaccine studies. Using a cut-off value of 0.1 IU/mL, the sensitivity, specificity, and concordance of the micro-neutralization test were 100%, 97.5%, and 98%, respectively. The geometric mean titer of all samples above the cut-off was 2.0 IU/mL using RFFIT and 3.4 IU/mL using the micro-neutralization test, indicating that titers determined using the micro-neutralization test are not equivalent to RFFIT titers. Based on four rVNA-positive hamster serum samples, the intra-assay coefficient of variability was 24% and inter-assay coefficient of variability was 30.4%. These results support continued use of the micro-neutralization test to determine rabies virus neutralizing antibody titers for low-volume serum samples.

Highlights

  • Measurement of rabies virus neutralizing antibody is essential to evaluating pre- or post-exposure prophylaxis and rabies diagnosis in humans and vaccination status in domestic animals [1,2,3]

  • Developed in 1973 as a replacement for the mouse neutralization test, the rapid fluorescent focus inhibition test (RFFIT) represented a major advance in cost, time, and replacement of animal use [5]

  • The RFFIT method requires a minimum volume of 50 μL of serum per test [10]

Read more

Summary

Introduction

Measurement of rabies virus neutralizing antibody (rVNA) is essential to evaluating pre- or post-exposure prophylaxis and rabies diagnosis in humans and vaccination status in domestic animals [1,2,3]. The RFFIT method has been modified to use mouse neuroblastoma cells in place of BHK cells [6], to use a 96-well format similar to the tissue culture serum neutralization test or more widely used fluorescent antibody virus neutralization (FAVN) test [7,8,9], and to use half the volume of reagents. Despite these modifications, the RFFIT method requires a minimum volume of 50 μL of serum per test [10]

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call